Skip to main content

Guardion Health Sciences Product Licensee Receives Registration Approval in Malaysia for Immune Support Supplement

Written by Customer Service on . Posted in Public Companies.

SAN DIEGO, Aug. 27, 2020 (GLOBE NEWSWIRE) — Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI) today announced that Ho Wah Genting Berhad (“HWGB”), a Malaysian company listed on the Malaysian Stock Exchange (KLSE:9601), has received product registration approval for Astramern Nutra V, an immune support dietary supplement designed and produced by Guardion. The approval of Astramern Nutra V by the Malaysian National Pharmaceutical Regulatory Agency (“NPRA”), which is effective through August 21, 2025, represents an important step in HWGB’s efforts to market and distribute Astramern Nutra V in Malaysia.
In early 2020, HWGB entered into a Manufacturing and Supply Agreement with Guardion for Guardion to design and manufacture two immune support dietary supplements, Astramern Nutra V, a vitamin formulation, and Astramern Nutra H, an herb formulation. HWGB’s healthcare subsidiary, Astramern Sdn Bhd, has an exclusive license to use and distribute these products in certain territories. The two products will be packaged together for sale by HWGB in Malaysia. Product registration approval of Astramern Nutra H is pending with the NPRA. Guardion fulfilled HWGB’s initial product order of $890,000 in June 2020.Astramern Nutra V is provided in capsule form and includes several important vitamins known to support the immune system and healthy bodily function, most notably N-acetyl-L-cysteine, which helps to replenish cellular glutathione, one of the body’s most potent antioxidants.Dr. David Evans, Ph.D., Guardion’s interim President and Chief Executive Officer, commented, “We are pleased that Ho Wah Genting Berhad has obtained product registration approval for Astramern Nutra V. Immune support dietary supplements represent a rapidly growing sector of the nutraceutical industry, and we believe that our expertise in developing and delivering unique immune support products in this sector will be a key component of future revenue growth in the United States and abroad.”About Guardion Health Sciences, Inc.

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.